By Richard Jefferys The CD4 cell count at which combination antiretroviral therapy should be started is a central, unresolved issue in the care of HIV-1-infected patients. -- When to Start Consortium, "Timing of Initiation of Antiretroviral Therapy in AIDS-free HIV-1…
AIDS Drug Assistance Programs Face a Dire Situation as Waiting Lists Expand for HIV Treatment In the midst of increasing state health budget cuts and service eliminations, people living with HIV/AIDS and advocates are worried about increasing AIDS drug assistance…
“The Vancouver of Implementation Science” meets the “Fund the Fund” Demonstration at the Cape Town AIDS Conference By Mark Harrington The Difference of a Decade For anyone who had been at the Durban, South Africa, AIDS Conference in mid- 2000,…
As the health care reform debate continues, TAG line’s Tracy Swan spoke with James Braun, doctor of osteopathy, a pioneering HIV physician, about how the epidemic has changed, and how our health care system can begin to meet the…
First Signal of Vaccine-Mediated Protection Against HIV Infection is Both Celebrated and Questioned By Richard Jefferys On September 24, 2009, the surprising announcemnet that a vaccine combination had shown efficacy in preventing HIV infection was splashed across the world media…
Are we doing all we can to boost adherence to antiretroviral treatment? Can packaging help people take their drugs more consistently? By Bob Huff My doctor recently gave me a starter pack for a new medication. The pills were packaged…
HIV is not in recession: This was the recurring theme of the IAS conference repeated in speeches and displayed on PowerPoint presentations. By Scott W. Morgan At the Fifth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in…
By Bob Huff At the International AIDS Conference in Durban, South Africa, in 2000, when the movement to provide universal access to antiretroviral treatment for people with HIV around the world began in earnest, guidelines for the standard-of-care treatment of…
Research Funding Gaps Revealed Treatment Action Group has published two new reports on the crisis in national and international funding for scientific research on AIDS, tuberculosis (TB), and viral hepatitis. TB and hepatitis are diseases that affect hundreds of millions…
By Gregg Gonsalves Adapted from remarks given on May 12, 2009, at the Carnegie Institution for Science in Washington, D.C., at a celebration for the 25th anniversary of the Multicenter AIDS Cohort Study (MACS), an ongoing prospective study of the…